This morning, Nephron hosted Dr. Albert Vilella for a conversation focused on next generation sequencing (NGS) and genomics technologies.  Topics of discussion included investment trends in NGS, an overview on the differentiation amongst new platforms under development, a discussion on the relative cost and quality of different systems, and how the competitive landscape could change over the next few years.